U.S. flag

An official website of the United States government

GRCh37/hg19 13q21.2-34(chr13:61534068-115107733)x3 AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 28, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003484899.1

Allele description [Variation Report for GRCh37/hg19 13q21.2-34(chr13:61534068-115107733)x3]

GRCh37/hg19 13q21.2-34(chr13:61534068-115107733)x3

Genes:
Variant type:
copy number gain
Cytogenetic location:
13q21.2-34
Genomic location:
Chr13: 61534068 - 115107733 (on Assembly GRCh37)
Preferred name:
GRCh37/hg19 13q21.2-34(chr13:61534068-115107733)x3
HGVS:

    Condition(s)

    Synonyms:
    none provided
    Identifiers:
    MedGen: C3661900

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...

    Assertion and evidence details

    Submission AccessionSubmitterReview Status
    (Assertion method)
    Clinical Significance
    (Last evaluated)
    OriginMethodCitations
    SCV004230760Quest Diagnostics Nichols Institute San Juan Capistrano
    criteria provided, single submitter

    (ACMG/ClinGen CNV Guidelines, 2019)
    Pathogenic
    (Jan 28, 2023)
    unknownclinical testing

    PubMed (1)
    [See all records that cite this PMID]

    Summary from all submissions

    EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
    not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

    Citations

    PubMed

    Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen).

    Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, Raca G, Ritter DI, South ST, Thorland EC, Pineda-Alvarez D, Aradhya S, Martin CL.

    Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6. Erratum in: Genet Med. 2021 Nov;23(11):2230. doi: 10.1038/s41436-021-01150-9.

    PubMed [citation]
    PMID:
    31690835
    PMCID:
    PMC7313390

    Details of each submission

    From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV004230760.1

    #EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
    1not providednot providednot providednot providedclinical testing PubMed (1)

    Description

    Duplications of the 13q terminal region are associated with a range of phenotypic outcomes (Brogna 2020, Douglas 2017, Habedank 1979, Krygier 2014, Phadke 2004, Ribacoba 2008, Rivas 1984, Tharapel 1984, Wei 2012). Therefore, based on current medical literature, this copy number variant (CNV) is classified as pathogenic. References: Brogna et al., Brain Sci. 2020 Dec 26;11(1):21. PMID: 33375380 Douglas et al., Am J Med Genet A. 2017 Jun;173(6):1673-1680. PMID: 28394407 Habedank et al., Hum Genet. 1979 Nov 1;52(1):91-9. PMID: 527979 Krygier et al., Clin Dysmorphol. 2014 Oct;23(4):155-7. PMID: 25144153 Phadke et al., Indian Pediatr. 2004 Jun;41(6):614-7. PMID: 15235171 Ribacoba et al., Int Arch Med. 2008 Apr 29;1(1):5. PMID: 18471271 Rivas et al., Hum Genet. 1984;67(1):86-93. PMID: 6745930 Tharapel et al., Indian J Pediatr. 1984 Jul-Aug;51(411):481-7. PMID: 6526455 Wei et al., Case Rep Genet. 2012;2012:821347. PMID: 23133763

    #SampleMethodObservation
    OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
    1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

    Last Updated: Sep 1, 2024